Vimta Labs Limited audio recording of Q4 FY 2025-26 Earnings Call under Regulation 30 held on 06 May 2026

1 min read     Updated on 07 May 2026, 02:30 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Vimta Labs Limited disclosed the availability of the audio recording for the Q4 FY 2025-26 Earnings and Investor Call held on 06 May 2026. The recording is hosted on the company's website, with a direct link provided for stakeholder access. This regulatory filing, signed by Company Secretary Sujani Vasireddi, adheres to SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
39637651

*this image is generated using AI for illustrative purposes only.

Vimta Labs Limited has informed the stock exchanges of the availability of the audio recording of its Q4 FY2025-26 Earnings and Investor Call, held on 06 May 2026. The disclosure was submitted to both BSE Limited and the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call Disclosure Details

The communication, referenced under VLL\SE\013\2026-27 and dated 06 May 2026, confirms that the audio recording of the Q4 FY2025-26 Earnings Call is now accessible on the company's official website. The key details of the disclosure are summarised below:

Parameter: Details
Event: Q4 FY 2025-26 Earnings / Investor Call
Date of Call: 06 May 2026
Regulatory Reference: Regulation 30, SEBI (LODR) Regulations, 2015
Recording Availability: Company's official website
Disclosure Reference No.: VLL\SE\013\2026-27
Signatory: Sujani Vasireddi, Company Secretary and Compliance Officer

Access to Recording

The audio recording of the earnings call is available for stakeholders and investors on the company's website for their information and necessary records. The specific link to the recording is: https://vimta.com/wp-content/uploads/10042586.mp3 .

Regulatory Compliance

The filing was signed by Sujani Vasireddi, Company Secretary and Compliance Officer of Vimta Labs Limited, and submitted to both BSE Limited and the National Stock Exchange of India Limited. The disclosure is in line with the company's obligations under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency and timely access to investor communications.

Historical Stock Returns for Vimta Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+3.23%+12.76%+24.87%-22.79%-0.81%+324.37%

What key financial metrics or guidance did Vimta Labs management highlight during the Q4 FY2025-26 earnings call that could signal the company's growth trajectory for FY2026-27?

How might Vimta Labs' Q4 FY2025-26 performance compare against its peers in the contract research and testing laboratory sector, and what does this imply for competitive positioning?

Are there any strategic expansions, new service offerings, or capital allocation plans discussed by Vimta Labs that could materially impact its revenue mix in the coming fiscal year?

Vimta Labs Reports Strong Q4 Performance with Rising Profit, Revenue, and Improved EBITDA Margins

1 min read     Updated on 07 May 2026, 12:39 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Vimta Labs reported Q4 standalone net profit of 211M rupees, up from 183.2M rupees year-on-year, while revenue grew to 1.1B rupees from 944.4M rupees. EBITDA improved to 393M rupees from 330M rupees, with EBITDA margin expanding to 36.04% from 34.98% year-on-year. The board also recommended a dividend of 2 rupees per share for the period.

powered bylight_fuzz_icon
39640140

*this image is generated using AI for illustrative purposes only.

Vimta Labs has reported a strong set of financial results for Q4, with standalone net profit climbing to 211M rupees compared to 183.2M rupees in the corresponding quarter of the previous year, reflecting a healthy year-on-year improvement. Revenue for the quarter also rose significantly to 1.1B rupees from 944.4M rupees in the year-ago period, underscoring the company's continued growth trajectory.

Key Financial Highlights

The company's quarterly performance demonstrated improvement across all major financial metrics. The following table summarizes the key financial figures for the quarter:

Metric: Q4 Current Q4 Previous (YoY)
Standalone Net Profit: 211M rupees 183.2M rupees
Revenue: 1.1B rupees 944.4M rupees
EBITDA: 393M rupees 330M rupees
EBITDA Margin: 36.04% 34.98%

Operating Profitability Strengthens

Vimta Labs posted EBITDA of 393M rupees for Q4, up from 330M rupees in the year-ago quarter, indicating stronger operational efficiency. The EBITDA margin expanded to 36.04% from 34.98% year-on-year, reflecting improved cost management and operating leverage during the period.

Dividend Recommendation

In addition to the financial results, the company's board has recommended a dividend of 2 rupees per share, rewarding shareholders for the period. This announcement signals the company's confidence in its financial position and commitment to returning value to its investors.

Historical Stock Returns for Vimta Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+3.23%+12.76%+24.87%-22.79%-0.81%+324.37%

How might Vimta Labs sustain its EBITDA margin expansion beyond 36% in upcoming quarters given potential cost pressures in the pharmaceutical testing sector?

Could Vimta Labs' strong revenue growth attract increased competition or potential acquisition interest from larger contract research organizations?

What capacity expansion or capital expenditure plans is Vimta Labs likely to announce to support its accelerating revenue trajectory?

More News on Vimta Labs

1 Year Returns:-0.81%